Actively Recruiting
Effects of Kaltenborn and Mulligan Mobilisation in Patients With Carpal Tunnel Syndrome.
Led by Riphah International University · Updated on 2024-11-13
48
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Carpal Tunnel Syndrome is the most common mononeuropathy that results from the compression of median nerve in carpal tunnel, leading to entrapment neuropathy. The symptoms become aggravated during drawing, typing or playing video games. The aim of study will be to compare the effects of Kaltenborn and Mulligan mobilisation on pain, disability and hand function in patients with carpal tunnel syndrome.
CONDITIONS
Official Title
Effects of Kaltenborn and Mulligan Mobilisation in Patients With Carpal Tunnel Syndrome.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Both genders between 20 and 45 years of age
- Localized pain, tingling, and numbness in the median nerve distribution
- Positive Tinel sign and positive Phalen's test
You will not qualify if you...
- Sensory or motor deficit in the ulnar or radial nerve or traumatic neck injury
- Previous hand surgery, trauma, or cervical radiculopathy
- Systemic diseases such as diabetes mellitus, thyroid disease, or rheumatoid arthritis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ejaz Hospital
Lahore, Punjab Province, Pakistan
Actively Recruiting
Research Team
I
Imran Amjad, Phd
CONTACT
I
Imran Amjad, Phd
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here